This bill introduces new regulations regarding the provision of chemical abortion drugs in New Hampshire. It defines "chemical" and "medical abortion" drugs and mandates that medical facilities and pharmacies that dispense these drugs must post a standardized notice about the potential reversibility of mifepristone, a commonly used drug for inducing abortions. The notice must be prominently displayed in various locations within the facilities, including patient waiting rooms and consultation areas, and must inform patients that mifepristone may not always be effective in ending a pregnancy and that reversal may be possible if the second pill has not been taken.

Additionally, the bill establishes enforcement mechanisms, including class B felony charges for healthcare providers or pharmacies that knowingly fail to comply with the notice requirements. It also allows women who have not received the required notice to pursue civil action for damages related to psychological or physical injuries resulting from the violation. The bill aims to ensure that women are adequately informed about their options regarding chemical abortions and the potential for reversing the effects of mifepristone. The act will take effect 60 days after its passage.